Dileep Bhagwat's Net Worth
$9.73 Thousand
Who is Dileep Bhagwat?
Dileep Bhagwat does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EPICEPT CORP, and BRADLEY PHARMACEUTICALS INC.
SEC CIK
Dileep Bhagwat's CIK is 0001141757
Past Insider Trading and Trends
2007 was Dileep Bhagwat's most active year for acquiring shares with 7 total transactions. Dileep Bhagwat's most active month to acquire stocks was the month of December. 2003 was Dileep Bhagwat's most active year for disposing of shares, totalling 2 transactions. Dileep Bhagwat's most active month to dispose stocks was the month of August. 2003 saw Dileep Bhagwat paying a total of $16,536.37 for 1,877 shares, this is the most they've acquired in one year. In 2003 Dileep Bhagwat cashed out on 3,754 shares for a total of $69,843.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EPICEPT CORP No price found
Senior VP - Pharma. Devel.Dileep Bhagwat owns 12,500 units of Common Stock, par value $0.0001. From 2006 to 2011 Dileep Bhagwat acquired a total of 12,500 shares in EPICEPT CORP at a cost of $18,287.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +400.00% | 10K |
$1.43 | $14,275.00 | 12.5K |
Dec 12
| |||
Form 4
| +150.00% | 1.5K |
$1.60 | $2,400.00 | 2.5K |
Aug 24
| |||
Form 4
|
∞
| 1K |
$1.61 | $1,612.00 | 1K |
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BRADLEY PHARMACEUTICALS INC No price found
VP - Research and DevelopmentDileep Bhagwat owns 10,226 units of Common Stock.acquired a total of 9,877 shares in BRADLEY PHARMACEUTICALS INC at a cost of $25,285.97, Dileep also disposed a total of 1,877 shares of BRADLEY PHARMACEUTICALS INC equalling to $53,306.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +353.04% | 8.01K |
$12.67 | $8,919.35 | 10.28K |
Dec 12 - Jan 8
| |||
Form 4
| +90.91% | 20 |
$28.16 | $563.20 | 42 |
Nov 13
| |||
Form 4
|
∞
| 22 |
$26.35 | $579.70 | 22 |
Oct 20
| |||
Form 4
|
—
|
0
|
$18.61 | -$36,770.43 | 2.23K |
Sep 10 - Sep 12
| |||
| No matching records found | |||||||||